Nika Pharmaceuticals markets analysis and €8.5B projected revenue

1 month ago 2

Healthcare

Nika Pharmaceuticals (OTCPK:NIKA) has previously reported an estimated potential €7.9B in revenue from its distribution agreement in Nigeria.
With similar contact terms for the UAE, Ukraine, Iraq, Jordan, and Syria, NIKA will receive €1,980/each set of ITV-1 with two sets necessary for one treatment.

Recommended For You

More Trending News

Read Entire Article